Clinical trial
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients…
NCT00071266 · Kos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00071266 |
|---|---|
| Title | The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC |
| Official title | The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design |
| Lead sponsor | Kos Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intermittent Claudication, Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | Niacin Extended Release and Lovastatin Tablets |
| Enrollment | 870 |
| Start date | Oct 1, 2003 |
| First posted | Oct 20, 2003 |
| Last update posted | Nov 2, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: